A

Absci pricing

As a listed company Absci reports revenue, spending and cash, and Eli Lilly's $40 million strategic investment in June 2026 carries no program rights. Terms of individual partnerships are not disclosed.

Absci full profile Absci alternatives

Pricing terms

How Absci pricing works

Pricing model: Drug creation partnerships with milestones and royalties. No software or service is sold at a list price.
Implementation: Not applicable. Nothing is installed in a partner's environment.
Business associate agreement: The platform works with laboratory and partner data rather than health records, and Absci makes no business associate statement.

Compared on price

Absci pricing against its alternatives

Published prices for Absci and the products closest to it. Each figure is as the vendor publishes it, in its own currency and billing unit.

All Absci alternatives →

A
AbsciNo published price
G
Generate:BiomedicinesNot applicable
A
AntiverseNo published price
C
Chai DiscoveryNo published price
B
BigHat BiosciencesNo published price
N
Nabla BioNo published price
I
Insilico MedicineNo published price
L
Latent LabsFree tier, then paid usage
B
Biolojic DesignNo published price

Questions

Absci pricing, answered

How much does Absci cost?

Absci does not publish a price. As a listed company Absci reports revenue, spending and cash, and Eli Lilly's $40 million strategic investment in June 2026 carries no program rights. Terms of individual partnerships are not disclosed.

Does Absci charge an implementation fee?

Not applicable. Nothing is installed in a partner's environment.

Does Absci offer a business associate agreement?

The platform works with laboratory and partner data rather than health records, and Absci makes no business associate statement.